Company research
Old API Wind-down Ltd.
CIK 1660719Updated Nov 16, 2026
Name history
Aralez Pharmaceuticals Inc. · through Jan 18, 2019
Filing activity
Latest filing
50 filings on record · 8-K, 25-NSE, DEFA14A, DEF 14A, 10-Q, 10-K/A.
Recent filings
Show 5 more recent filings
Financials
FY 2017 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| ASSETS | |||
| AssetsUSD | 453,477,000Source | 517,377,000Source | 32,258,000Source |
| Property, Plant and Equipment, NetUSD | 7,453,000Source | 7,316,000Source | 251,000Source |
| GoodwillUSD | 81,781,000Source | 76,694,000Source | — |
| Current assets: | |||
| Cash and Cash Equivalents, at Carrying ValueUSD | 28,892,000Source | 64,943,000Source | 24,816,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 13,453,000Source | 20,405,000Source | 5,966,000Source |
| Inventory, NetUSD | 6,643,000Source | — | — |
| Assets, CurrentUSD | 52,675,000Source | 92,331,000Source | 32,007,000Source |
| Other Assets, NoncurrentUSD | 1,222,000Source | 842,000Source | — |
| LIABILITIES AND EQUITY | |||
| LiabilitiesUSD | 438,258,000Source | 397,891,000Source | 17,475,000Source |
| Stockholders’ equity: | |||
| Common Stock, Value, IssuedUSD | — | — | 33,000Source |
| Additional Paid in CapitalUSD | 363,792,000Source | 352,336,000Source | 149,438,000Source |
| Retained Earnings (Accumulated Deficit)USD | -362,871,000Source | -237,666,000Source | -134,688,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 14,298,000Source | 4,816,000Source | — |
| Stockholders' Equity Attributable to ParentUSD | 15,219,000Source | 119,486,000Source | 14,783,000Source |
| Liabilities and EquityUSD | 453,477,000Source | 517,377,000Source | 32,258,000Source |
| Current liabilities: | |||
| Liabilities, CurrentUSD | 67,860,000Source | 57,274,000Source | 16,489,000Source |
| Accounts Payable, CurrentUSD | 23,631,000Source | 8,833,000Source | 4,557,000Source |
| Deferred Income Tax Liabilities, NetUSD | 3,797,000Source | 3,273,000Source | — |
| Other Liabilities, NoncurrentUSD | 3,182,000Source | 2,218,000Source | 986,000Source |
| Additional Financial Items | |||
| Accrued Liabilities, CurrentUSD | 28,496,000Source | 32,141,000Source | 11,932,000Source |
| Deferred Tax Liabilities, NetUSD | 3,774,000Source | 2,444,000Source | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 274,546,000Source | 274,441,000Source | — |
cash flow · annual statements
| Line item | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -125,205,000Source | — | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation, Depletion and AmortizationUSD | 35,801,000Source | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 11,348,000Source | 11,865,000Source | 7,043,000Source |
| Changes in operating assets and liabilities: | |||
| Increase (Decrease) in Accounts ReceivableUSD | -4,614,000Source | 7,694,000Source | 337,000Source |
| Increase (Decrease) in InventoriesUSD | 1,811,000Source | 819,000Source | — |
| Increase (Decrease) in Accounts PayableUSD | 14,694,000Source | -282,000Source | 3,950,000Source |
| Deferred Income Tax Expense (Benefit)USD | 1,066,000Source | -3,952,000Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -28,786,000Source | — | — |
| Cash flows from investing activities: | |||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | 217,887,000Source | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -1,514,000Source | — | — |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | 215,000Source | — | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | 1,822,000Source | 4,166,000Source | 240,000Source |
| Cash flows from financing activities: | |||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -6,233,000Source | — | — |
| Supplemental disclosure of cash flow information: | |||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 24,820,000Source | — | — |
| Income Taxes Paid, NetUSD | 3,310,000Source | — | — |
| Additional Financial Items | |||
| Amortization of Debt Issuance CostsUSD | 106,000Source | 84,000Source | — |
| Depreciation, Amortization and Accretion, NetUSD | 1,500,000Source | 400,000Source | 20,000Source |
| Foreign Currency Transaction Gain (Loss), UnrealizedUSD | 48,000Source | 100,000Source | — |
| Gain (Loss) on Sale of InvestmentsUSD | — | — | -199,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | 272,000Source | -200,000Source | — |
| GoodwillUSD | 81,781,000Source | 76,694,000Source | — |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | 4,368,000Source | — |
| Income Tax Expense (Benefit)USD | 2,400,000Source | -64,000Source | 174,000Source |
| Net Income (Loss) Attributable to ParentUSD | -125,205,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -125,205,000Source | -102,978,000Source | -37,783,000Source |
| Other Nonoperating Income (Expense)USD | 682,000Source | 5,683,000Source | -143,000Source |
| Proceeds from Issuance of Common StockUSD | — | 75,000,000Source | 1,735,000Source |
income statement · annual statements
| Line item | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Total RevenueUSD | 105,947,000Source | 54,270,000Source | 21,391,000Source |
| Selling, General and Administrative ExpenseUSD | 116,572,000Source | 118,548,000Source | 50,345,000Source |
| Operating Income (Loss)USD | -96,503,000Source | -102,584,000Source | -37,466,000Source |
| Other Nonoperating Income (Expense)USD | 682,000Source | 5,683,000Source | -143,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -122,805,000Source | -103,042,000Source | -37,609,000Source |
| Income Tax Expense (Benefit)USD | 2,400,000Source | -64,000Source | 174,000Source |
| Net Income (Loss) Attributable to ParentUSD | -125,205,000Source | — | — |
| Earnings Per Share, BasicUSD per share | -1.89Source | -1.67Source | -1.16Source |
| Earnings Per Share, DilutedUSD per share | -1.89Source | -1.74Source | -1.16Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 66,389,000Source | 61,830,967Source | 32,589,795Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 66,389,000Source | 61,883,016Source | 32,589,795Source |
| Additional Financial Items | |||
| Costs and ExpensesUSD | 202,450,000Source | 156,854,000Source | 58,857,000Source |
| Current Income Tax Expense (Benefit)USD | 1,334,000Source | 3,888,000Source | 174,000Source |
| Interest ExpenseUSD | 26,984,000Source | — | — |
| Interest Income (Expense), Nonoperating, NetUSD | — | -6,141,000Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -125,205,000Source | -102,978,000Source | -37,783,000Source |
| Research and Development ExpenseUSD | 2,324,000Source | 8,832,000Source | 8,512,000Source |
| Sales Revenue, Goods, Net (Deprecated 2018-01-31)USD | 38,729,000Source | 25,432,000Source | — |